KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $72.4 million.

  • Fulgent Genetics' Total Current Liabilities fell 211.38% to $72.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.4 million, marking a year-over-year decrease of 211.38%. This contributed to the annual value of $72.9 million for FY2024, which is 16.3% down from last year.
  • Fulgent Genetics' Total Current Liabilities amounted to $72.4 million in Q3 2025, which was down 211.38% from $71.3 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Total Current Liabilities registered a high of $196.5 million during Q1 2021, and its lowest value of $61.4 million during Q3 2023.
  • Its 5-year average for Total Current Liabilities is $95.8 million, with a median of $75.9 million in 2024.
  • As far as peak fluctuations go, Fulgent Genetics' Total Current Liabilities soared by 328261.62% in 2021, and later tumbled by 4917.23% in 2023.
  • Over the past 5 years, Fulgent Genetics' Total Current Liabilities (Quarter) stood at $105.3 million in 2021, then dropped by 16.34% to $88.1 million in 2022, then fell by 17.13% to $73.0 million in 2023, then fell by 0.16% to $72.9 million in 2024, then decreased by 0.65% to $72.4 million in 2025.
  • Its Total Current Liabilities stands at $72.4 million for Q3 2025, versus $71.3 million for Q2 2025 and $65.9 million for Q1 2025.